# Ep192: Kate Haviland on Following the Science to Precision Immunology

Page: https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep192-kate-haviland-on-following-the-science-to-precision-immunology
Text version: https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep192-kate-haviland-on-following-the-science-to-precision-immunology.md
Podcast: [The Long Run with Luke Timmerman](https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799)
Published: 2026-01-08T16:40:33+00:00
Episode link: https://soundcloud.com/longrunpodcast/longrun_ep192
Audio file: https://feeds.soundcloud.com/stream/2243995649-longrunpodcast-longrun_ep192.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep192-kate-haviland-on-following-the-science-to-precision-immunology
Duration seconds: 5166

## Resource

Kate Haviland, former CEO of Blueprint Medicines, on how the company transitioned to a precision immunology company and was acquired by Sanofi for $9.5 billion.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep192-kate-haviland-on-following-the-science-to-precision-immunology/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep192-kate-haviland-on-following-the-science-to-precision-immunology.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.